FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

Immunity

Volumn 12, Issue 6, 2000, Pages 599-609

  Sprick, Martin R ^a   Weigand, Markus A ^a,b   Rieser, Eva ^a   Rauch, Charles T ^c   Juo, Peter ^d   Blenis, John ^d   Krammer, Peter H ^a   Walczak, Henning ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c AMGEN INC   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CASPASE 8; DEATH RECEPTOR 4; FAS ASSOCIATED DEATH DOMAIN PROTEIN; TRALL RECEPTOR 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRECIPITATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033667778     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80211-3     Document Type: Article

References (61)

1. Apoptosis control by death and decoy receptors
2. Safety and antitumor activity of recombinant soluble Apo2 ligand
3. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain
4. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
5. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway
6. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
7. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
8. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
9. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
10. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
11. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11
12. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
13. Functional analysis of TRAIL receptors using monoclonal antibodies
14. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL
15. The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism of the Danish population
16. Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity
17. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade
18. FADD is required for multiple signaling events downstream of the receptor Fas
19. Use of a membranelocalized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry
20. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells
21. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs
22. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity
23. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells
24. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
25. CD95(APO-1/Fas)-mediated apoptosis: Live and let die
26. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes
27. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL
28. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage
29. A novel receptor for Apo2L/TRAIL contains a truncated death domain
30. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles
31. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
32. Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): A new receptor protecting lymphocytes from the death ligand TRAIL
33. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: Evidence for TRAIL induction via the T Cell receptor signaling pathway
34. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
35. Apoptosis by death factor
36. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
37. Lethal effect of the anti-Fas antibody in mice
38. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
39. The receptor for the cytotoxic ligand TRAIL
40. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signaling
41. The death receptors
42. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
43. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity
44. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b
45. Characterization of two receptors for TRAIL
46. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB
47. TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL
48. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
49. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells
50. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally
51. Measles virus induces functional TRAIL production by human dendritic cells
52. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction
53. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
54. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
55. Tumor necrosis factor receptor and Fas signaling mechanisms
56. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II
57. Identification and characterization of a new member of the TNF family that induces apoptosis
58. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
59. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells
60. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1
61. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells